Review



randomised clinical trial  (Tayside Pharmaceuticals)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Tayside Pharmaceuticals randomised clinical trial
    Characteristics of the studied cohorts.
    Randomised Clinical Trial, supplied by Tayside Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/randomised+clinical+trial/randomised+clinical+trial/pmc08457475-53-29-31
    Average 90 stars, based on 1 article reviews
    randomised clinical trial - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "LTA4H rs2660845 association with montelukast response in early and late-onset asthma"

    Article Title: LTA4H rs2660845 association with montelukast response in early and late-onset asthma

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0257396

    Characteristics of the studied cohorts.
    Figure Legend Snippet: Characteristics of the studied cohorts.

    Techniques Used: Variant Assay

    Association of exacerbation under montelukast treatment with rs2660845 genotype.
    Figure Legend Snippet: Association of exacerbation under montelukast treatment with rs2660845 genotype.

    Techniques Used:

    Related Articles

    Variant Assay:

    Article Title: LTA4H rs2660845 association with montelukast response in early and late-onset asthma
    Article Snippet: In this study, we utilised a very large dataset, consisting of previously described, ethnically diverse case-control studies (GALA II and SAGE), asthma cohorts (BREATHE and PAGES), a randomised clinical trial (RCT) (Tayside RCT) and two large real-life cohorts (the UKBiobank and GoSHARE), to explore the association of rs2660845 with lack of montelukast treatment response.



    Similar Products

    randomised clinical trial  (Transmet Corporation)
    90
    Transmet Corporation randomised clinical trial
    Randomised Clinical Trial, supplied by Transmet Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/randomised+clinical+trial/randomised+clinical+trial/pm40563695-94-37-23
    Average 90 stars, based on 1 article reviews
    randomised clinical trial - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    randomised and nonrandomised clinical trials  (Wolters Kluwer Health)
    90
    Wolters Kluwer Health randomised and nonrandomised clinical trials
    Randomised And Nonrandomised Clinical Trials, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/randomised+clinical+trial/randomised+and+nonrandomised+clinical+trials/10__1097_slash_qco__0000000000000970-39-26-19
    Average 90 stars, based on 1 article reviews
    randomised and nonrandomised clinical trials - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    randomised clinical trial  (Tayside Pharmaceuticals)
    90
    Tayside Pharmaceuticals randomised clinical trial
    Characteristics of the studied cohorts.
    Randomised Clinical Trial, supplied by Tayside Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/randomised+clinical+trial/randomised+clinical+trial/pmc08457475-53-29-31
    Average 90 stars, based on 1 article reviews
    randomised clinical trial - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    empa-heart cardiolink-6 randomised clinical trial  (Cardiolink Corporation)
    90
    Cardiolink Corporation empa-heart cardiolink-6 randomised clinical trial
    Characteristics of the studied cohorts.
    Empa Heart Cardiolink 6 Randomised Clinical Trial, supplied by Cardiolink Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/randomised+clinical+trial/empa+heart+cardiolink+6+trial/pm32157772-350-18-19
    Average 90 stars, based on 1 article reviews
    empa-heart cardiolink-6 randomised clinical trial - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    randomised phase 3 clinical trial  (Gilead Sciences)
    99
    Gilead Sciences randomised phase 3 clinical trial
    Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.
    Randomised Phase 3 Clinical Trial, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/randomised+clinical+trial/VEKLURY/pmc07828218-135-6-26
    Average 99 stars, based on 1 article reviews
    randomised phase 3 clinical trial - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Characteristics of the studied cohorts.

    Journal: PLoS ONE

    Article Title: LTA4H rs2660845 association with montelukast response in early and late-onset asthma

    doi: 10.1371/journal.pone.0257396

    Figure Lengend Snippet: Characteristics of the studied cohorts.

    Article Snippet: In this study, we utilised a very large dataset, consisting of previously described, ethnically diverse case-control studies (GALA II and SAGE), asthma cohorts (BREATHE and PAGES), a randomised clinical trial (RCT) (Tayside RCT) and two large real-life cohorts (the UKBiobank and GoSHARE), to explore the association of rs2660845 with lack of montelukast treatment response.

    Techniques: Variant Assay

    Association of exacerbation under montelukast treatment with rs2660845 genotype.

    Journal: PLoS ONE

    Article Title: LTA4H rs2660845 association with montelukast response in early and late-onset asthma

    doi: 10.1371/journal.pone.0257396

    Figure Lengend Snippet: Association of exacerbation under montelukast treatment with rs2660845 genotype.

    Article Snippet: In this study, we utilised a very large dataset, consisting of previously described, ethnically diverse case-control studies (GALA II and SAGE), asthma cohorts (BREATHE and PAGES), a randomised clinical trial (RCT) (Tayside RCT) and two large real-life cohorts (the UKBiobank and GoSHARE), to explore the association of rs2660845 with lack of montelukast treatment response.

    Techniques:

    Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.

    Journal: Biomolecules

    Article Title: Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm

    doi: 10.3390/biom11010091

    Figure Lengend Snippet: Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.

    Article Snippet: Infliximab is currently tested in a randomised phase 3 clinical trial among other immune-modulating candidates for treating COVID-19 as an add-on therapy to the already approved remdesivir (Gilead Sciences, Inc., Foster City, CA, USA) (NCT04593940).

    Techniques: Injection, Variant Assay